The Role of Metacognition in the Prediction of Depressive and Anxiety Symptoms in Chronically Ill Patients
- PMID: 38592170
- PMCID: PMC10932318
- DOI: 10.3390/jcm13051306
The Role of Metacognition in the Prediction of Depressive and Anxiety Symptoms in Chronically Ill Patients
Abstract
Introduction: Cancer, diabetes, and heart diseases are frequent causes of depression and anxiety. The study explored the metacognitive beliefs manifested by chronically ill patients and the presence of depressive or anxiety symptoms and the predictive role of metacognition in both.
Methods: A total of 254 chronically ill patients participated in the study. The Metacognitive Questionnaire was used to measure the patients' metacognitive beliefs, whereas the Hospital Anxiety and Depression Scale was applied to evaluate their psychopathological symptoms. A correlation analysis was performed to explore the relationships between metacognition and psychopathological symptoms. Regression analyses were conducted to examine the predictive role of metacognition in anxiety and depression.
Results: The Negative Beliefs about Uncontrollability and Danger scale correlated with both anxiety and depression scales, and the Cognitive Confidence scale correlated with the depression scale. Linear regression analyses indicated that metacognitive beliefs were responsible for 32.2% of the variance of anxiety symptoms among all the chronically ill. Metacognitive beliefs accounted for 48.8% of the variance in anxiety symptoms and 36.6% in depressive symptoms among diabetes patients.
Conclusions: There are specific correlations between psychopathological symptoms and metacognition among chronically ill patients. Metacognitions have a moderate role in developing and sustaining anxiety and depressive symptoms.
Keywords: anxiety; chronic illness; depression; metacognition; metacognitive beliefs.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Testing relationships between metacognitive beliefs, anxiety and depression in cardiac and cancer patients: Are they transdiagnostic?J Psychosom Res. 2019 Sep;124:109738. doi: 10.1016/j.jpsychores.2019.109738. Epub 2019 Jun 11. J Psychosom Res. 2019. PMID: 31443817
-
The relationship between metacognitive beliefs and symptoms in eating disorders.Psychiatriki. 2020 Jul-Sep;31(3):225-235. doi: 10.22365/jpsych.2020.313.225. Psychiatriki. 2020. PMID: 33099463
-
Anxiety and depression in people with epilepsy: The contribution of metacognitive beliefs.Seizure. 2017 Aug;50:153-159. doi: 10.1016/j.seizure.2017.06.012. Epub 2017 Jun 20. Seizure. 2017. PMID: 28667910
-
Metacognitive beliefs and their relationship with anxiety and depression in physical illnesses: A systematic review.PLoS One. 2020 Sep 10;15(9):e0238457. doi: 10.1371/journal.pone.0238457. eCollection 2020. PLoS One. 2020. PMID: 32911486 Free PMC article.
-
Relationships between metacognitive beliefs and anxiety and depression in children and adolescents: A meta-analysis.J Affect Disord. 2024 Sep 15;361:36-50. doi: 10.1016/j.jad.2024.05.123. Epub 2024 May 28. J Affect Disord. 2024. PMID: 38815761
References
-
- Małyszczak K., Pyszel A., Pawłowski T., Czarnecki M., Kiejna A. Generalized anxiety and neuroticism in patients suffering from somatic diseases. Psychiatr. Pol. 2008;42:219–228. - PubMed
-
- Quattropani M.C., Lenzo V., Mucciardi M., Toffle M.E. The Role of Metacognitions in Predicting Anxiety and Depression Levels in Cancer Patients Ongoing Chemotherapy. Procedia Soc. Behav. Sci. 2015;205:463–473. doi: 10.1016/j.sbspro.2015.09.042. - DOI
Grants and funding
LinkOut - more resources
Full Text Sources